Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Transcatheter Heart Valve Market – Insights

Transcatheter heart valve implantation is a minimally-invasive procedure to repair damaged heart valves with bioprosthetic valves for treatment of valvular heart disease (VHD), namely aortic stenosis and mitral regurgitation. It is an alternative approach to conventional open heart surgery and is especially recommended for extremely high risk patients.

Statistics:

The global transcatheter heart valve market is estimated to account for US$ 7,642.7 Mn in terms of value by the end of 2027.

Global Transcatheter Heart Valve Market: Drivers

Increasing prevalence of VHD is a major factor boosting growth of the global transcatheter heart valve market over the forecast period. For instance, according to the study, ‘Epidemiology and Trends of Aortic Stenosis Mortality in the United States (1999-2016)’, published in Journal of the American College of Cardiology in March 2019, aortic stenosis was associated with a mortality rate of 106.3 per 1 million persons, with highest mortality rate in non-Hispanic whites followed by Hispanics, and non-Hispanic blacks. Moreover, the study noticed increase in age-adjusted mortality between the period.

Therefore, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the World Health Organization, geriatric population is expected to reach 2 billion by 2050, up from 900 million in 2015.

North America region held dominant position in the global transcatheter heart valve market in 2019, accounting for 53.6% share in terms of value, followed by Europe.

Figure 1. Global Transcatheter Heart Valve Market Share (%), by Region, 2019

Transcatheter Heart Valve  | Coherent Market Insights

Global Transcatheter Heart Valve Market: Restraints

High cost of transcatheter heart valves is expected to hinder growth of the global transcatheter heart valve market. For instance, the average cost of transcatheter aortic valve replacement (TAVR) devices is US$ 32,000 as compared to US$ 4,000–US$ 7,000 for surgical aortic valve replacement (SAVR) devices.

Moreover, TAVR is associated with some risks and complications such as artery damage due to insertion of catheter that can lead to major bleeding, valve leakage, infection, kidney failure, heart attack, major stroke, and fatality during procedure.

Global Transcatheter Heart Valve Market: Opportunities

Players in the market can focus on development and launch of affordable TAVR products in order to enhance their share in emerging market such as India, China, and Brazil.

Moreover, there is rising concern about cerebrovascular events that can occur after TAVR, which are associated with increased mortality. Therefore, development of standardized definitions and assessments of neurological endpoints for TAVR and other cardiac interventions is also expected to offer lucrative growth opportunities for players in the market.

Transcatheter Heart Valve  | Coherent Market Insights

Transfemoral Approach segment in the global transcatheter heart valve market was valued at US$ 2,369.4 Mn in 2019 and is expected to reach US$ 6,814.2 Mn by 2025 at a CAGR of 14.1% during the forecast period.

Market Trends/Key Takeaways

Major hospitals are focused on adopting TAVR for the treatment of aortic stenosis. For instance, in January 2020, Chester County Hospital announced that TAVR will be available in a couple of months at appropriate patients at the hospital.

Several regulatory bodies are focused on extending the indications of transcatheter heart valves. For instance, in August 2019, the U.S. Food and Drug Administration approved an expanded indication for several transcatheter heart valves that include, Sapien 3, Sapien 3 Ultra, CoreValve Evolut R, and CoreValve Evolut PRO for patients with severe aortic valve stenosis.

Regulations:

U.S.

  • In the U.S., FDA Center for Device and Radiological Health (FDA/CDRH) is responsible for regulation of medical devices
  • TAVR is categorized by FDA/CDRH as a class III significant risk device, which requires demonstration of safety and effectiveness for approval as part of the premarket approval (PMA) process.

Global Transcatheter Heart Valve Market: Competitive Landscape

Major players operating in the global transcatheter heart valve market include, Edwards Lifesciences Corporation, Medtronic, Boston Scientific Corporation, Abbott, JenaValve Technology, SYMETIS, and Braile Biomedica.

Global Transcatheter Heart Valve Market: Key Developments

Major players in the market are focused on product approval and launch to expand their product portfolio. For instance, in January 2020, JenaValve Technology received the U.S. FDA’s breakthrough device designation for its pericardial TAVR device.

In November 2019, Edwards Lifesciences Corporation received CE Mark to expand use of the Edwards SAPIEN 3 transcatheter heart valve for the treatment of patients diagnosed with aortic stenosis who are at low risk for open-heart surgery.

Transcatheter heart valve implantation is a minimally-invasive procedure to repair damaged heart valves with bio-prosthetic valves for treatment of valvular heart disease (VHD). It is an alternative approach to conventional open heart surgery and is especially recommended for extremely high risk patients. TAVR is approved by the US FDA for treating individuals suffering from symptomatic aortic stenosis and are at high risk for standard valve replacement surgery. Increasing demand for minimally-invasive procedures is expected to boost growth of the global transcatheter heart valve market over the forecast period

Key features of the study:

  • This report provides in-depth analysis of the Transcatheter Heart Valve market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global Transcatheter Heart Valve market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Edwards Lifesciences Corporation, Medtronic, Boston Scientific Corporation, Abbott, JenaValve Technology, SYMETIS, and Braile Biomedica.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Transcatheter Heart Valve market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Transcatheter Heart Valve market

Detailed Segmentation:

Segmentation

  • Transcatheter Heart Valve Market, By Product Type:
    • TAVR
    • TMVR
  • Transcatheter Heart Valve Market, By Delivery Systems:
    • Transfemoral Approach
    • Transapical Approach
    • Transaortic Approach
  • Transcatheter Heart Valve Market, By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Cardiac Catheterization Laboratory
  • Transcatheter Heart Valve Market, By Region:
    • North America
      • By Product Type:
        • TAVR
        • TMVR
      • By Delivery Systems
        • Transfemoral Approach
        • Transapical Approach
        • Transaortic Approach
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Cardiac Catheterization Laboratory
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • TAVR
        • TMVR
      • By Delivery Systems
        • Transfemoral Approach
        • Transapical Approach
        • Transaortic Approach
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Cardiac Catheterization Laboratory
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • TAVR
        • TMVR
      • By Delivery Systems
        • Transfemoral Approach
        • Transapical Approach
        • Transaortic Approach
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Cardiac Catheterization Laboratory
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • TAVR
        • TMVR
      • By Delivery Systems
        • Transfemoral Approach
        • Transapical Approach
        • Transaortic Approach
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Cardiac Catheterization Laboratory
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • TAVR
        • TMVR
      • By Delivery Systems
        • Transfemoral Approach
        • Transapical Approach
        • Transaortic Approach
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Cardiac Catheterization Laboratory
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • TAVR
        • TMVR
      • By Delivery Systems
        • Transfemoral Approach
        • Transapical Approach
        • Transaortic Approach
      • By End User:
        • Hospitals
        • Ambulatory Surgical Centers
        • Cardiac Catheterization Laboratory
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Edwards Lifesciences Corporation*
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Medtronic
    • Boston Scientific Corporation
    • Abbott
    • JenaValve Technology
    • SYMETIS
    • Braile Biomedica

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Delivery System
      • Market Snippet, By End User
      • Market Snippet, By Region Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Highlights
    • Awareness Initiatives
    • PEST Analysis
    • Epidemiology
  4. Global Transcatheter Heart Valve Market, By Product Type, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • TAVR
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • TMVR
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Global Transcatheter Heart Valve Market, By Delivery System, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Transfemoral Approach
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Transapical Approach
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Transaortic Approach
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Transcatheter Heart Valve Market, By End User, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Ambulatory Surgical Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Cardiac Catheterization Laboratory
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global Transcatheter Heart Valve Market, By Region, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Delivery System, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Delivery System, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Delivery System, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Delivery System, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Delivery System, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Delivery System, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  8. Competitive Landscape
    • Company Profiles
      • Edwards Lifesciences Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Medtronic
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Boston Scientific Corporation
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Abbott
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      •  JenaValve Technology
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • SYMETIS
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Braile Biomedica
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  9. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 18 market data tables and 12 figures on “Transcatheter Heart Valve Market - Global forecast to 2027”.

Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner